John Gelly
Internal Medicine · Marietta, GANPI 1851381164
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 239 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,290 and has fallen 98.5% since, to $19 in 2025.
Across 239 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$748
- Amgen$743
- AstraZeneca$376
- Astellas Pharma US Inc$263
- Novo Nordisk$259
- Takeda Pharmaceuticals U.S.A., Inc.$185
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,83097%
- Education$1353%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $748 |
| Amgen | 39 | $743 |
| AstraZeneca | 26 | $376 |
| Astellas Pharma US Inc | 10 | $263 |
| Novo Nordisk | 14 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $185 |
| Merck | 11 | $155 |
| Lilly USA, LLC | 10 | $151 |
| Amarin Pharma, Inc. | 10 | $140 |
| Pfizer | 9 | $139 |
| Boehringer Ingelheim | 6 | $113 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Johnson & Johnson | 6 | $93 |
| GSK | 4 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $67 |
| Sunovion Pharmaceuticals Inc. | 4 | $52 |
| Bayer | 2 | $39 |
| Abbott | 2 | $35 |
| Eisai Inc. | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Radius Health, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Gilead | 1 | $12 |
| Aytu Biopharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,964 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Marietta
- Ebon BourneMarietta$242K
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.